1. Home
  2. NTHI vs PRPL Comparison

NTHI vs PRPL Comparison

Compare NTHI & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • PRPL
  • Stock Information
  • Founded
  • NTHI 2008
  • PRPL 2010
  • Country
  • NTHI United States
  • PRPL United States
  • Employees
  • NTHI N/A
  • PRPL N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • PRPL Home Furnishings
  • Sector
  • NTHI Health Care
  • PRPL Consumer Discretionary
  • Exchange
  • NTHI Nasdaq
  • PRPL Nasdaq
  • Market Cap
  • NTHI 142.5M
  • PRPL 96.8M
  • IPO Year
  • NTHI N/A
  • PRPL N/A
  • Fundamental
  • Price
  • NTHI $7.24
  • PRPL $0.80
  • Analyst Decision
  • NTHI
  • PRPL Hold
  • Analyst Count
  • NTHI 0
  • PRPL 2
  • Target Price
  • NTHI N/A
  • PRPL $1.25
  • AVG Volume (30 Days)
  • NTHI 108.1K
  • PRPL 1.2M
  • Earning Date
  • NTHI 01-01-0001
  • PRPL 05-06-2025
  • Dividend Yield
  • NTHI N/A
  • PRPL N/A
  • EPS Growth
  • NTHI N/A
  • PRPL N/A
  • EPS
  • NTHI N/A
  • PRPL N/A
  • Revenue
  • NTHI $79,990.00
  • PRPL $472,015,000.00
  • Revenue This Year
  • NTHI N/A
  • PRPL N/A
  • Revenue Next Year
  • NTHI N/A
  • PRPL $10.65
  • P/E Ratio
  • NTHI N/A
  • PRPL N/A
  • Revenue Growth
  • NTHI 13.52
  • PRPL N/A
  • 52 Week Low
  • NTHI $4.11
  • PRPL $0.56
  • 52 Week High
  • NTHI $25.00
  • PRPL $1.50
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • PRPL 50.76
  • Support Level
  • NTHI N/A
  • PRPL $0.78
  • Resistance Level
  • NTHI N/A
  • PRPL $0.86
  • Average True Range (ATR)
  • NTHI 0.00
  • PRPL 0.07
  • MACD
  • NTHI 0.00
  • PRPL -0.01
  • Stochastic Oscillator
  • NTHI 0.00
  • PRPL 12.91

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

Share on Social Networks: